5 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Nello Mainolfi
SpringWorks Therapeutics
5 followers
Genesis Therapeutics
1 follower
Adverum Biotech
8 followers
Vanguard Clinical
1 follower
4D Molecular Therapeutics
3 followers
GenScript
3 followers
Quantum-Si
2 followers
Worldwide Clinical Trials
4 followers
Scholar Rock
1 follower
Caribou Biosciences
1 follower
Valo
1 follower
Explore companies